| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium adolescentis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium adolescentis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bifidobacterium angulatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Oxtriphylline |
Click to Show/Hide the Detail |
| Drug ID |
DR1217
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium angulatum co-metabolize the drug Oxtriphylline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [5] |
| Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium breve co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium breve co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium breve co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium breve co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium breve co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium longum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Hesperetin |
Click to Show/Hide the Detail |
| Drug ID |
DR0808
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Hesperetin, and Bifidobacterium longum further metabolizes its metabolite (3-(3'-hydroxyphenyl)propionic acid), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [10] |
| Hesperetin |
Click to Show/Hide the Detail |
| Drug ID |
DR0808
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Hesperetin, and Bifidobacterium longum further metabolizes its metabolite (3-(4'-hydroxyphenyl)propionic acid), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [10] |
| Hesperetin |
Click to Show/Hide the Detail |
| Drug ID |
DR0808
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Hesperetin, and Bifidobacterium longum further metabolizes its metabolite (Dihydrocaffeic acid), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [10] |
| Hesperetin |
Click to Show/Hide the Detail |
| Drug ID |
DR0808
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Hesperetin, and Bifidobacterium longum further metabolizes its metabolite (Hydroxy-4-Methoxybenzenepropanoic Acid), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [10] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium longum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium ruminatum co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium ruminatum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluvoxamine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0740
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium ruminatum co-metabolize the drug Fluvoxamine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium ruminatum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium ruminatum co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bifidobacterium ruminatum co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Collinsella aerofaciens (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Loxapine succinate |
Click to Show/Hide the Detail |
| Drug ID |
DR0989
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Collinsella aerofaciens co-metabolize the drug Loxapine succinate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [2] |
| Collinsella intestinalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Collinsella intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Collinsella intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Dopamine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0532
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Eggerthella lenta co-metabolize the drug Dopamine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [17] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Eggerthella lenta co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Enterorhabdus mucosicola (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BIO-300 |
Click to Show/Hide the Detail |
| Drug ID |
DR0768
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug BIO-300, and Enterorhabdus mucosicola further metabolizes its metabolite (Dihydrogenistein), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[18], [19] |
| Nocardia farcinica (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Nocardia farcinica co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [21] |
| Slackia isoflavoniconvertens (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BIO-300 |
Click to Show/Hide the Detail |
| Drug ID |
DR0768
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Slackia isoflavoniconvertens co-metabolize the drug BIO-300, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [22] |
| Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Streptomyces avermitilis co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [24], [25] |
| Bacteria: Bacteroidetes |
| Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Alistipes indistinctus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Alistipes indistinctus co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Alistipes indistinctus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Alistipes indistinctus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Alistipes indistinctus co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Bacteroides caccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| NAB-365 |
Click to Show/Hide the Detail |
| Drug ID |
DR0338
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides caccae co-metabolize the drug NAB-365, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides caccae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides caccae co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides caccae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides cellulosilyticus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides cellulosilyticus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides cellulosilyticus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides coprophilus co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides coprophilus co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides coprophilus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides coprophilus co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Ergotamine tartrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0600
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides coprophilus co-metabolize the drug Ergotamine tartrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides coprophilus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Olanzapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1186
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides coprophilus co-metabolize the drug Olanzapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides coprophilus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Procarbazine |
Click to Show/Hide the Detail |
| Drug ID |
DR1344
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides coprophilus co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides coprophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| Anagrelide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0112
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Anagrelide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Diclofenac sodium, and Bacteroides dorei further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[23], [37] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Griseofulvin |
Click to Show/Hide the Detail |
| Drug ID |
DR0791
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Griseofulvin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Procarbazine |
Click to Show/Hide the Detail |
| Drug ID |
DR1344
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides dorei co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides eggerthii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides eggerthii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides eggerthii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides eggerthii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides eggerthii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides eggerthii co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Bacteroides finegoldii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides finegoldii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides finegoldii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 19 Drugs Metabolized
|
| Anagrelide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0112
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Anagrelide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Ergotamine tartrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0600
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Ergotamine tartrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Griseofulvin |
Click to Show/Hide the Detail |
| Drug ID |
DR0791
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Griseofulvin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Lofexidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0967
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Lofexidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Olanzapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1186
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Olanzapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Procarbazine |
Click to Show/Hide the Detail |
| Drug ID |
DR1344
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Warfarin sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1717
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides fragilis co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[41], [2] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides intestinalis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides ovatus co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides ovatus co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides ovatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides ovatus co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides ovatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides ovatus co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides ovatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides ovatus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Procarbazine |
Click to Show/Hide the Detail |
| Drug ID |
DR1344
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides ovatus co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides ovatus co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| BIO-300 |
Click to Show/Hide the Detail |
| Drug ID |
DR0768
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug BIO-300, and Bacteroides sartorii further metabolizes its metabolite (Dihydrogenistein), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[18], [42] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Griseofulvin |
Click to Show/Hide the Detail |
| Drug ID |
DR0791
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Griseofulvin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Procarbazine |
Click to Show/Hide the Detail |
| Drug ID |
DR1344
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides sartorii co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides stercoris co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides stercoris co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides stercoris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides stercoris co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides stercoris co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Procarbazine |
Click to Show/Hide the Detail |
| Drug ID |
DR1344
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides stercoris co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides stercoris co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides stercoris co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Ergotamine tartrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0600
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Ergotamine tartrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Griseofulvin |
Click to Show/Hide the Detail |
| Drug ID |
DR0791
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Griseofulvin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Procarbazine |
Click to Show/Hide the Detail |
| Drug ID |
DR1344
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides thetaiotaomicron co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Ergotamine tartrate |
Click to Show/Hide the Detail |
| Drug ID |
DR0600
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides uniformis co-metabolize the drug Ergotamine tartrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides uniformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides uniformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides uniformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Griseofulvin |
Click to Show/Hide the Detail |
| Drug ID |
DR0791
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Griseofulvin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[43], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Procarbazine |
Click to Show/Hide the Detail |
| Drug ID |
DR1344
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Verapamil hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1681
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Verapamil hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[44], [2] |
| Warfarin sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1717
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides vulgatus co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[41], [2] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
| Anagrelide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0112
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Anagrelide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Griseofulvin |
Click to Show/Hide the Detail |
| Drug ID |
DR0791
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Griseofulvin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Procarbazine |
Click to Show/Hide the Detail |
| Drug ID |
DR1344
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides xylanisolvens co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
| Anagrelide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0112
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Anagrelide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Clonidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0352
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Clonidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Olanzapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1186
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Olanzapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Procarbazine |
Click to Show/Hide the Detail |
| Drug ID |
DR1344
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Odoribacter splanchnicus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides distasonis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides distasonis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Griseofulvin |
Click to Show/Hide the Detail |
| Drug ID |
DR0791
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides distasonis co-metabolize the drug Griseofulvin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides distasonis co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Naproxen |
Click to Show/Hide the Detail |
| Drug ID |
DR1130
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides distasonis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides distasonis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides distasonis co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides distasonis co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides distasonis co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides johnsonii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Estrone sulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0650
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides johnsonii co-metabolize the drug Estrone sulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[45], [46] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides johnsonii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides johnsonii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides johnsonii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides johnsonii co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides johnsonii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides merdae co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides merdae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides merdae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides merdae co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Parabacteroides merdae co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Prevotella buccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Estrone sulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0650
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Prevotella buccae co-metabolize the drug Estrone sulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[45], [47], [48] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Prevotella copri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Prevotella copri co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Prevotella copri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Prevotella copri co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Prevotella copri co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Prevotella copri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Tannerella forsythia (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BIO-300 |
Click to Show/Hide the Detail |
| Drug ID |
DR0768
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Tannerella forsythia co-metabolize the drug BIO-300, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [42] |
| Bacteria: Firmicutes |
| Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Anaerobutyricum hallii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Anaerobutyricum hallii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Anaerobutyricum hallii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Anaerococcus hydrogenalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Anaerococcus hydrogenalis co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Anaerococcus hydrogenalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Anaerostipes hadrus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Anaerostipes hadrus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[43], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Anaerostipes hadrus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Anaerotruncus colihominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Anaerotruncus colihominis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Anaerotruncus colihominis co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[49], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Anaerotruncus colihominis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacillus megaterium co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [51] |
| Chlorzoxazone |
Click to Show/Hide the Detail |
| Drug ID |
DR0312
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacillus megaterium co-metabolize the drug Chlorzoxazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[52], [53], [51] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacillus megaterium co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [54] |
| Nifedipine |
Click to Show/Hide the Detail |
| Drug ID |
DR1152
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacillus megaterium co-metabolize the drug Nifedipine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[55], [53], [51] |
| Propranolol hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1367
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacillus megaterium co-metabolize the drug Propranolol hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[56], [57] |
| Bacteroides pectinophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides pectinophilus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides pectinophilus co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides pectinophilus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides pectinophilus co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Bacteroides pectinophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| Anagrelide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0112
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Anagrelide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Cyclobenzaprine |
Click to Show/Hide the Detail |
| Drug ID |
DR0390
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Cyclobenzaprine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluvoxamine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0740
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Fluvoxamine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Thiothixene |
Click to Show/Hide the Detail |
| Drug ID |
DR1584
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia hansenii co-metabolize the drug Thiothixene, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Blautia luti (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia luti co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Blautia luti co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridioides difficile co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [60] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridioides difficile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridioides difficile co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridioides difficile co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 16 Drugs Metabolized
|
| Anagrelide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0112
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Anagrelide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Cyclobenzaprine |
Click to Show/Hide the Detail |
| Drug ID |
DR0390
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Cyclobenzaprine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[58], [2] |
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Fluvoxamine maleate |
Click to Show/Hide the Detail |
| Drug ID |
DR0740
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Fluvoxamine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Paroxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1245
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Paroxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [2] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[49], [2] |
| Procarbazine |
Click to Show/Hide the Detail |
| Drug ID |
DR1344
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Thiothixene |
Click to Show/Hide the Detail |
| Drug ID |
DR1584
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium botulinum co-metabolize the drug Thiothixene, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [2] |
| Clostridium scindens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium scindens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium scindens co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Clostridium spiroforme (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium spiroforme co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium spiroforme co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium spiroforme co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium sporogenes co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium sporogenes co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium sporogenes co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium sporogenes co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium sporogenes co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Clostridium symbiosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium symbiosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium symbiosum co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Clostridium symbiosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Coprococcus comes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Coprococcus comes co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Coprococcus comes co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Dorea formicigenerans co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Dorea formicigenerans co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Dorea formicigenerans co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterocloster asparagiformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterocloster asparagiformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterocloster bolteae co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterocloster bolteae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterocloster bolteae co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterocloster bolteae co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterocloster bolteae co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[49], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterocloster bolteae co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterocloster bolteae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterococcus faecalis co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [60] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterococcus faecalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterococcus faecalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterococcus faecalis co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Erysipelatoclostridium ramosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Erysipelatoclostridium ramosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Erysipelatoclostridium ramosum co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Eubacterium ramulus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BIO-300 |
Click to Show/Hide the Detail |
| Drug ID |
DR0768
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Eubacterium ramulus co-metabolize the drug BIO-300, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [62] |
| Eubacterium rectale (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Eubacterium rectale co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Eubacterium rectale co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Eubacterium ventriosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Eubacterium ventriosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Eubacterium ventriosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Eubacterium ventriosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Diclofenac sodium, and Faecalibacterium prausnitzii further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[23], [37] |
| Menadione |
Click to Show/Hide the Detail |
| Drug ID |
DR1022
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Faecalibacterium prausnitzii co-metabolize the drug Menadione, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [64] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Anagrelide hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0112
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Holdemanella biformis co-metabolize the drug Anagrelide hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Holdemanella biformis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Holdemanella biformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Holdemanella biformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Holdemanella biformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Hungatella hathewayi co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Hungatella hathewayi co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Hungatella hathewayi co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Hungatella hathewayi co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Lactobacillus acetotolerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Oxtriphylline |
Click to Show/Hide the Detail |
| Drug ID |
DR1217
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Lactobacillus acetotolerans co-metabolize the drug Oxtriphylline, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [5] |
| Lactobacillus johnsonii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Tegafur |
Click to Show/Hide the Detail |
| Drug ID |
DR1539
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Lactobacillus johnsonii co-metabolize the drug Tegafur, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [65] |
| Lactobacillus reuteri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Dasatinib |
Click to Show/Hide the Detail |
| Drug ID |
DR0423
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Lactobacillus reuteri co-metabolize the drug Dasatinib, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Lactobacillus reuteri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Lactobacillus reuteri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Lactobacillus reuteri co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Lactobacillus rhamnosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Diclofenac sodium, and Lactobacillus rhamnosus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[23], [37] |
| Hesperetin |
Click to Show/Hide the Detail |
| Drug ID |
DR0808
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Hesperetin, and Lactobacillus rhamnosus further metabolizes its metabolite (3-(3'-hydroxyphenyl)propionic acid), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [10] |
| Hesperetin |
Click to Show/Hide the Detail |
| Drug ID |
DR0808
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Hesperetin, and Lactobacillus rhamnosus further metabolizes its metabolite (3-(4'-hydroxyphenyl)propionic acid), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [10] |
| Hesperetin |
Click to Show/Hide the Detail |
| Drug ID |
DR0808
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Hesperetin, and Lactobacillus rhamnosus further metabolizes its metabolite (Dihydrocaffeic acid), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [10] |
| Hesperetin |
Click to Show/Hide the Detail |
| Drug ID |
DR0808
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Hesperetin, and Lactobacillus rhamnosus further metabolizes its metabolite (Hydroxy-4-Methoxybenzenepropanoic Acid), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[9], [10] |
| Lactobacillus sakei (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Erythromycin stearate |
Click to Show/Hide the Detail |
| Drug ID |
DR0614
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Lactobacillus sakei co-metabolize the drug Erythromycin stearate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[66], [67], [68] |
| Marvinbryantia formatexigens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Marvinbryantia formatexigens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Carvedilol |
Click to Show/Hide the Detail |
| Drug ID |
DR0282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Roseburia intestinalis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Roseburia intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Roseburia intestinalis co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Roseburia intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Roseburia intestinalis co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Roseburia intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Diclofenac sodium, and Ruminococcus gnavus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[23], [37] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Ruminococcus gnavus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Ruminococcus gnavus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Ruminococcus gnavus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Ruminococcus gnavus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Ruminococcus lactaris (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Ruminococcus lactaris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Ruminococcus lactaris co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Ruminococcus lactaris co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Ruminococcus lactaris co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Ruminococcus torques (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Ruminococcus torques co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Ruminococcus torques co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Subdoligranulum variabile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Idebenone |
Click to Show/Hide the Detail |
| Drug ID |
DR0853
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Subdoligranulum variabile co-metabolize the drug Idebenone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Subdoligranulum variabile co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Subdoligranulum variabile co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Bacteria: Lentisphaerae |
| Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Victivallis vadensis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteria: Proteobacteria |
| Acinetobacter baumannii (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Pyrazinamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1372
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Acinetobacter baumannii co-metabolize the drug Pyrazinamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[69], [70] |
| Citrobacter freundii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Citrobacter freundii co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [60] |
| Edwardsiella tarda (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Edwardsiella tarda co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Edwardsiella tarda co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Enterobacter cancerogenus (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterobacter cancerogenus co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterobacter cancerogenus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterobacter cancerogenus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Enterobacter cancerogenus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Escherichia coli co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[50], [60] |
| Conjugated estrogens |
Click to Show/Hide the Detail |
| Drug ID |
DR0377
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Escherichia coli co-metabolize the drug Conjugated estrogens, which can collectively affect efficacy, safety or bioavailability of this drug. |
[71], [72] |
| Duloxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0554
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Escherichia coli co-metabolize the drug Duloxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Flunitrazepam |
Click to Show/Hide the Detail |
| Drug ID |
DR0712
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Escherichia coli co-metabolize the drug Flunitrazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [73] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Escherichia coli co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Escherichia coli co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[27], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Escherichia coli co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Primaquine |
Click to Show/Hide the Detail |
| Drug ID |
DR1339
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Escherichia coli co-metabolize the drug Primaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| SRT-501 |
Click to Show/Hide the Detail |
| Drug ID |
DR1406
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Escherichia coli co-metabolize the drug SRT-501, which can collectively affect efficacy, safety or bioavailability of this drug. |
[74], [75] |
| Neisseria sicca (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Ethanol |
Click to Show/Hide the Detail |
| Drug ID |
DR0655
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Neisseria sicca co-metabolize the drug Ethanol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [76] |
| Novosphingobium aromaticivorans (alpha-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Conjugated estrogens |
Click to Show/Hide the Detail |
| Drug ID |
DR0377
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Novosphingobium aromaticivorans co-metabolize the drug Conjugated estrogens, which can collectively affect efficacy, safety or bioavailability of this drug. |
[71], [77] |
| Proteus penneri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Proteus penneri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Proteus penneri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Proteus penneri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Providencia alcalifaciens (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Providencia alcalifaciens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Providencia rettgeri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Providencia rettgeri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Providencia stuartii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Providencia stuartii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Providencia stuartii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Providencia stuartii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
| Pseudomonas putida (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nicotine |
Click to Show/Hide the Detail |
| Drug ID |
DR1148
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Pseudomonas putida co-metabolize the drug Nicotine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[78], [79] |
| Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Salmonella enterica co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Menadione |
Click to Show/Hide the Detail |
| Drug ID |
DR1022
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Salmonella enterica co-metabolize the drug Menadione, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [80], [81] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Salmonella enterica co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Bacteria: Verrucomicrobia |
| Akkermansia muciniphila (verrucomicrobiae) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Akkermansia muciniphila co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Akkermansia muciniphila co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[49], [2] |
| Riluzole |
Click to Show/Hide the Detail |
| Drug ID |
DR1425
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Akkermansia muciniphila co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [2] |
| Fungi: Ascomycota |
| Saccharomyces cerevisiae (ascomycota) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Acetaminophen |
Click to Show/Hide the Detail |
| Drug ID |
DR0037
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) metabolizes the drug Acetaminophen, and Saccharomyces cerevisiae further metabolizes its metabolite (1-Phenyl-1,2-propanedione), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[50], [60] |
| Archaea: Euryarchaeota |
| Methanobrevibacter oralis (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Methanobrevibacter oralis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [82] |
| Methanobrevibacter smithii (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Methanobrevibacter smithii co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [82] |
| Methanomassiliicoccus luminyensis (thermoplasmata) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Methanomassiliicoccus luminyensis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [82] |
| Methanosphaera stadtmanae (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 1A2 (CYP1A2) and Methanosphaera stadtmanae co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [82] |
|
|
|
|
|
|